Morgan Stanley (MS) 13D/13G Filings for Aerie Pharmaceuticals, Inc. (AERI)

Morgan Stanley 13D and 13G filings for Aerie Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-11-10
4:06 pm
Sale
2022-10-31 13G Aerie Pharmaceuticals, Inc.
AERI
MORGAN STANLEY
MS
384,245
0.800%
-3,686,147decrease
(-90.56%)
Filing
2022-02-09
1:28 pm
Purchase
2021-12-31 13G Aerie Pharmaceuticals, Inc.
AERI
MORGAN STANLEY
MS
4,070,392
8.600%
4,070,392increase
(New Position)
Filing